vonaprument
vonaprument: sourced relationships with 1 company · 2 clinical trials tracked.
vonaprument evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could vonaprument → ANNX affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (1)
| Company | Dated record stage |
|---|---|
| Annexon, Inc. (ANNX) | Phase 3 |
Clinical Trial Registry Records (2)
A Multicenter, Open-Label Extension Study of the Long-Term Safety of Vonaprument (ANX007) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy
Primary endpoint: Number of Participants with Treatment Emergent Adverse Events
A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 (Vonaprument) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy
Primary endpoint: Proportion of Participants Experiencing a Best Corrected Visual Acuity (BCVA) ≥15-letter Loss from Baseline Through Month 15 as Assessed by the Early Treatment Diabetic Retinopathy Study (ETDRS) Chart at Any Two Consecutive Visits
Frequently asked questions
Which companies have sourced relationships with vonaprument?
vonaprument has dated SEC/FDA relationship records for Annexon, Inc..
How many clinical trials involve vonaprument?
BioSniper tracks 2 clinical trials involving vonaprument.